http://orcid.org/0000-0002-0841-2216
Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Sarah Dahlberg, Ellen T Chang, Sheila R Weiss, Pamela Dopart, Errol Gould & Mary E Ritchey. (2022) Use of Contrave, Naltrexone with Bupropion, Bupropion, or Naltrexone and Major Adverse Cardiovascular Events: A Systematic Literature Review. Diabetes, Metabolic Syndrome and Obesity 15, pages 3049-3067.
Read now
Read now
Erin Kelty, Gary Hulse & David Joyce. (2020) A comparison of blood toxicology in fatalities involving alcohol and other drugs in patients with an opioid use disorder treated with methadone, buprenorphine, and implant naltrexone. The American Journal of Drug and Alcohol Abuse 46:2, pages 241-250.
Read now
Read now
Paolo Mannelli & Li-Tzy Wu. (2019) Opioid use disorder deaths and the effects of medication therapy. The American Journal of Drug and Alcohol Abuse 45:3, pages 227-229.
Read now
Read now
Articles from other publishers (18)
Gary Qian, Keith Humphreys, Jeremy D. Goldhaber-Fiebert & Margaret L. Brandeau. (2024) Estimated effectiveness and cost-effectiveness of opioid use disorder treatment under proposed U.S. regulatory relaxations: A model-based analysis. Drug and Alcohol Dependence 256, pages 111112.
Crossref
Crossref
Paige D Wartko, Jennifer F. Bobb, Denise M. Boudreau, Abigail G. Matthews, Jennifer McCormack, Amy K. Lee, Hongxiang Qiu, Onchee Yu, Noorie Hyun, Abisola E. Idu, Cynthia I. Campbell, Andrew J. Saxon, David S. Liu, Andrea Altschuler, Jeffrey H. Samet, Colleen T. Labelle, Mohammad Zare-Mehrjerdi, Angela L. Stotts, Jordan M. Braciszewski, Mark T. Murphy, Douglas Dryden, Julia H. Arnsten, Chinazo O. Cunningham, Viviana E. Horigian, José Szapocznik, Joseph E. Glass, Ryan M. Caldeiro, Rebecca C. Phillips, Mary Shea, Gavin Bart, Robert P. Schwartz, Jennifer McNeely, Jane M. Liebschutz, Judith I. Tsui, Joseph O. Merrill, Gwen T. Lapham, Megan Addis, Katharine A. Bradley, Megan M. Ghiroli, Leah K. Hamilton, Yong Hu, Jennifer S. LaHue, Amy M. Loree, Sean M. Murphy, Thomas F. Northrup, Dikla Shmueli-Blumberg, Angela J. Silva, Zoe M. Weinstein, Mark TinFook Wong & Rachael P. Burganowski. (2023) Nurse Care Management for Opioid Use Disorder Treatment. JAMA Internal Medicine 183:12, pages 1343.
Crossref
Crossref
Laura BrandtMei-Chen HuYing LiuFelipe CastilloGabriel J. OdomRaymond R. BaliseDaniel J. FeasterEdward V. NunesSean X. Luo. (2023) Risk of Experiencing an Overdose Event for Patients Undergoing Treatment With Medication for Opioid Use Disorder. American Journal of Psychiatry 180:5, pages 386-394.
Crossref
Crossref
Gary Qian, Isabelle Rao, Keith Humphreys, Douglas K. Owens & Margaret L. Brandeau. (2023) Cost-effectiveness of office-based buprenorphine treatment for opioid use disorder. Drug and Alcohol Dependence 243, pages 109762.
Crossref
Crossref
Daniel J. Gottlieb, Brian Shiner, Jessica E. Hoyt, Natalie B. Riblet, Talya Peltzman, Nikhil Teja & Bradley V. Watts. (2022) A comparison of mortality rates for buprenorphine versus methadone treatments for opioid use disorder. Acta Psychiatrica Scandinavica 147:1, pages 6-15.
Crossref
Crossref
Savitha Racha, Megan Buresh & Michael Fingerhood. (2022) Pharmacotherapy of Opioid Use Disorder—Update and Current Challenges. Psychiatric Clinics of North America 45:3, pages 335-346.
Crossref
Crossref
Hanis Mohammad Hazani, Isa Naina Mohamed, Mustapha Muzaimi, Wael Mohamed, Mohamad Fairuz Yahaya, Seong Lin Teoh, Rashidi Mohamed Pakri Mohamed, Mohd Fadzli Mohamad Isa, Sundus Mansoor Abdulrahman, Ravi Ramadah, Mohammad Rahim Kamaluddin & Jaya Kumar. (2022) Goofballing of Opioid and Methamphetamine: The Science Behind the Deadly Cocktail. Frontiers in Pharmacology 13.
Crossref
Crossref
Gerald Cochran, Evan S. Cole, Michael Sharbaugh, Dylan Nagy, Adam J. Gordon, Walid F. Gellad, Janice Pringle, Todd Bear, Jack Warwick, Coleman Drake, Chung-Chou H. Chang, Ellen DiDomenico, David Kelley & Julie Donohue. (2022) Provider and Patient-panel Characteristics Associated With Initial Adoption and Sustained Prescribing of Medication for Opioid Use Disorder. Journal of Addiction Medicine 16:2, pages e87-e96.
Crossref
Crossref
Erin Kelty, Agata Chrzanowska & David B. Preen. 2022. Handbook of Substance Misuse and Addictions. Handbook of Substance Misuse and Addictions
1851
1867
.
Sierra Ferguson & Aviva Teitelbaum. 2022. Addiction Medicine. Addiction Medicine
67
79
.
Erin Kelty, Agata Chrzanowska & David B. Preen. 2021. Handbook of Substance Misuse and Addictions. Handbook of Substance Misuse and Addictions
1
17
.
Katherine Herlinger & Anne Lingford-Hughes. (2021) Addressing unmet needs in opiate dependence: supporting detoxification and advances in relapse prevention. BJPsych Advances 27:6, pages 362-372.
Crossref
Crossref
Thomas SantoJrJr, Brodie Clark, Matt Hickman, Jason Grebely, Gabrielle Campbell, Luis Sordo, Aileen Chen, Lucy Thi Tran, Chrianna Bharat, Prianka Padmanathan, Grainne Cousins, Julie Dupouy, Erin Kelty, Roberto Muga, Bohdan Nosyk, Jeong Min, Raimondo Pavarin, Michael Farrell & Louisa Degenhardt. (2021) Association of Opioid Agonist Treatment With All-Cause Mortality and Specific Causes of Death Among People With Opioid Dependence. JAMA Psychiatry 78:9, pages 979.
Crossref
Crossref
Michael Fairley, Keith Humphreys, Vilija R. Joyce, Mark Bounthavong, Jodie Trafton, Ann Combs, Elizabeth M. Oliva, Jeremy D. Goldhaber-Fiebert, Steven M. Asch, Margaret L. Brandeau & Douglas K. Owens. (2021) Cost-effectiveness of Treatments for Opioid Use Disorder. JAMA Psychiatry 78:7, pages 767.
Crossref
Crossref
Ralph Foglia, Anna Kline & Nina A. Cooperman. (2021) New and Emerging Opioid Overdose Risk Factors. Current Addiction Reports 8:2, pages 319-329.
Crossref
Crossref
Priya Jain, Kimberley McKinnell, Rose Marino, Prashanthi Vunnava, Marie A. Liles-Burden, Avani Desai, Madé Wenten, James Fratantonio, Sarah C. Akerman, Maria A. Sullivan & Gary Bloomgren. (2020) Evaluation of Opioid Overdose Reports in Patients Treated with Extended-Release Naltrexone: Postmarketing Data from 2006 to 2018. Drug Safety 44:3, pages 351-359.
Crossref
Crossref
Erin Kelty, Gary Hulse, David Joyce & David B. Preen. (2020) Impact of Pharmacological Treatments for Opioid Use Disorder on Mortality. CNS Drugs 34:6, pages 629-642.
Crossref
Crossref
Rahimah Hassan, Cheah Pike See, Sasidharan Sreenivasan, Sharif M. Mansor, Christian P. Müller & Zurina Hassan. (2020) Mitragynine Attenuates Morphine Withdrawal Effects in Rats—A Comparison With Methadone and Buprenorphine. Frontiers in Psychiatry 11.
Crossref
Crossref